- Home
- CPAY vs TEVA Comparison
CPAY vs TEVA Comparison
Compare CPAY & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAY
- TEVA
- Stock Information
- Founded
- CPAY 1986
- TEVA 1901
- Country
- CPAY United States
- TEVA Israel
- Employees
- CPAY N/A
- TEVA N/A
- Industry
- CPAY EDP Services
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- CPAY Technology
- TEVA Health Care
- Exchange
- CPAY Nasdaq
- TEVA Nasdaq
- Market Cap
- CPAY 25.8B
- TEVA 23.7B
- IPO Year
- CPAY 2010
- TEVA N/A
- Fundamental
- Price
- CPAY $375.81
- TEVA $21.83
- Analyst Decision
- CPAY Buy
- TEVA Buy
- Analyst Count
- CPAY 12
- TEVA 7
- Target Price
- CPAY $387.64
- TEVA $22.43
- AVG Volume (30 Days)
- CPAY 462.3K
- TEVA 8.9M
- Earning Date
- CPAY 02-05-2025
- TEVA 01-29-2025
- Dividend Yield
- CPAY N/A
- TEVA N/A
- EPS Growth
- CPAY 9.84
- TEVA N/A
- EPS
- CPAY 14.01
- TEVA N/A
- Revenue
- CPAY $3,877,478,000.00
- TEVA $16,772,000,000.00
- Revenue This Year
- CPAY $8.44
- TEVA $5.74
- Revenue Next Year
- CPAY $11.75
- TEVA $4.46
- P/E Ratio
- CPAY $26.82
- TEVA N/A
- Revenue Growth
- CPAY 4.68
- TEVA 9.81
- 52 Week Low
- CPAY $247.10
- TEVA $11.48
- 52 Week High
- CPAY $385.30
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- CPAY 68.10
- TEVA 60.46
- Support Level
- CPAY $342.12
- TEVA $21.21
- Resistance Level
- CPAY $375.02
- TEVA $22.10
- Average True Range (ATR)
- CPAY 6.73
- TEVA 0.62
- MACD
- CPAY 3.92
- TEVA -0.11
- Stochastic Oscillator
- CPAY 98.73
- TEVA 69.42
About CPAY Corpay Inc.
Corpay Inc is a global S&P500 corporate payments company that helps businesses and consumers pay expenses in a simple, controlled manner. Its suite of modern payment solutions helps its customers better manage vehicle-related expenses (such as fueling and parking), travel expenses (e.g. hotel bookings), and payables (e.g. paying vendors). This results in its customers saving time and ultimately spending less.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.